1-3 of 3
Miles A Nunn, DPhil
Close
Sort by
Journal Articles

C5 Polymorphism in a Dutch Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH) and No Asian Ancestry, Resistant to Eculizumab, but in Vitro Sensitive to Coversin

Saskia Langemeijer, MD PhD, Jun-Ichi Nishimura, MD PhD, Wynne Weston-Davies, Miles A Nunn, DPhil, Yuzuru Kanakura, MD PhD, Ian J Mackie, Petra Muus, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1209.
https://doi.org/10.1182/blood.V126.23.1209.1209
Published: 2015
Journal Articles

Coversin Blocked in Vitro Hemolysis in an Eculizumab-Resistant PNH Patient with the C5 Polymorphism (c.2654G>A)

Yasutaka Ueda, MDPhD, Makiko Osato, DS, Wynne Weston-Davies, MB FRCS, Miles A Nunn, DPhil, Satoru Hayashi, Jun-Ichi Nishimura, MD PhD, Yuzuru Kanakura, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2138.
https://doi.org/10.1182/blood.V126.23.2138.2138
Published: 2015
Journal Articles

Clinical and Immunological Characterisation of Coversin, a Novel Small Protein Inhibitor of Complement C5 with Potential As a Therapeutic Agent in PNH and Other Complement Mediated Disorders

Wynne H Weston-Davies, MB FRCS, Miles A Nunn, DPhil, Fernando O Pinto, MDFRCPath, Ian J Mackie, PhDFRCPath, Stephen John Richards, PhD FRCPath, Samuel J Machin, MDFRCPath, Raymond Prudo, MB FRCP(C) MRCPsych, Peter Hillmen, MBChB, PhD
Journal: Blood
Blood (2014) 124 (21): 4280.
https://doi.org/10.1182/blood.V124.21.4280.4280
Published: 2014